Cargando…
Candidate imaging biomarkers for PMP22 ‐related inherited neuropathies
OBJECTIVE: Charcot–Marie–Tooth type 1A (CMT1A) and hereditary neuropathy with liability to pressure palsy (HNPP) are caused by mutations to the peripheral myelin protein 22 (PMP22) gene. A need exists for sensitive and reliable biomarkers of progression and treatment response. Magnetic resonance ima...
Autores principales: | Roth, Alison R., Li, Jun, Dortch, Richard D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268861/ https://www.ncbi.nlm.nih.gov/pubmed/35656877 http://dx.doi.org/10.1002/acn3.51561 |
Ejemplares similares
-
Clinical and Molecular Characterization of PMP22 point mutations in Taiwanese patients with Inherited Neuropathy
por: Liao, Yi-Chu, et al.
Publicado: (2017) -
A translatable RNAi-driven gene therapy silences PMP22/Pmp22 genes and improves neuropathy in CMT1A mice
por: Stavrou, Marina, et al.
Publicado: (2022) -
PMP22 related neuropathies: Charcot-Marie-Tooth disease type 1A and Hereditary Neuropathy with liability to Pressure Palsies
por: van Paassen, Barbara W, et al.
Publicado: (2014) -
Partial Gene Deletions of PMP22 Causing Hereditary Neuropathy with Liability to Pressure Palsies
por: Cho, Sun-Mi, et al.
Publicado: (2014) -
Afferent Visual Pathway Affection in Patients with PMP22 Deletion-Related Hereditary Neuropathy with Liability to Pressure Palsies
por: Brandt, Alexander U., et al.
Publicado: (2016)